These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3335995

  • 1. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK, Stitzer ML, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [Abstract] [Full Text] [Related]

  • 2. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [Abstract] [Full Text] [Related]

  • 3. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
    Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):485-91. PubMed ID: 2760839
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X, Farre M, Cami J.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [Abstract] [Full Text] [Related]

  • 5. Acute physical dependence: time course and relation to human plasma morphine concentrations.
    June HL, Stitzer ML, Cone E.
    Clin Pharmacol Ther; 1995 Mar; 57(3):270-80. PubMed ID: 7697945
    [Abstract] [Full Text] [Related]

  • 6. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
    Kirby KC, Stitzer ML, Heishman SJ.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):730-7. PubMed ID: 2243350
    [Abstract] [Full Text] [Related]

  • 7. Acute opioid physical dependence in humans: naloxone dose response effects.
    Heishman S, Stitzer M.
    NIDA Res Monogr; 1988 Nov; 81():195-201. PubMed ID: 3136361
    [No Abstract] [Full Text] [Related]

  • 8. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T, Miller JH, Irvine RJ.
    Life Sci; 2006 Jan 11; 78(7):682-8. PubMed ID: 16102783
    [Abstract] [Full Text] [Related]

  • 9. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May 11; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 10. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR, Hofford RS, Norris CJ, Eitan S.
    Behav Pharmacol; 2008 Dec 11; 19(8):805-11. PubMed ID: 19020415
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Rubinstein KJ.
    J Pharmacol Exp Ther; 1992 Jan 11; 260(1):355-63. PubMed ID: 1731046
    [Abstract] [Full Text] [Related]

  • 12. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT, Little PJ, Kuhn CM.
    J Pharmacol Exp Ther; 1995 Jun 11; 273(3):1361-74. PubMed ID: 7791109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
    Baraban SC, Stornetta RL, Guyenet PG.
    J Pharmacol Exp Ther; 1993 Apr 11; 265(1):89-95. PubMed ID: 8474034
    [Abstract] [Full Text] [Related]

  • 16. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 11; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 17. Human pharmacology of the opioid neuropeptide dynorphin A(1-13).
    Greenwald MK, Stitzer ML, Haberny KA.
    J Pharmacol Exp Ther; 1997 Jun 11; 281(3):1154-63. PubMed ID: 9190848
    [Abstract] [Full Text] [Related]

  • 18. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1993 Nov 11; 267(2):624-34. PubMed ID: 7504098
    [Abstract] [Full Text] [Related]

  • 19. Influence of sweet tasting solutions on opioid withdrawal.
    Jain R, Mukherjee K, Singh R.
    Brain Res Bull; 2004 Dec 15; 64(4):319-22. PubMed ID: 15561466
    [Abstract] [Full Text] [Related]

  • 20. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG.
    J Pharmacol Exp Ther; 2003 Mar 15; 304(3):1033-41. PubMed ID: 12604679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.